chr2-19994275-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002381.5(MATN3):c.1405+24C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.444 in 1,522,864 control chromosomes in the GnomAD database, including 153,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.46 ( 16044 hom., cov: 33)
Exomes 𝑓: 0.44 ( 137737 hom. )
Consequence
MATN3
NM_002381.5 intron
NM_002381.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.171
Genes affected
MATN3 (HGNC:6909): (matrilin 3) This gene encodes a member of von Willebrand factor A domain containing protein family. This family of proteins is thought to be involved in the formation of filamentous networks in the extracellular matrices of various tissues. This protein contains two von Willebrand factor A domains; it is present in the cartilage extracellular matrix and has a role in the development and homeostasis of cartilage and bone. Mutations in this gene result in multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 2-19994275-G-C is Benign according to our data. Variant chr2-19994275-G-C is described in ClinVar as [Benign]. Clinvar id is 258646.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.62 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.456 AC: 69280AN: 151898Hom.: 16020 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
69280
AN:
151898
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.473 AC: 108917AN: 230198 AF XY: 0.476 show subpopulations
GnomAD2 exomes
AF:
AC:
108917
AN:
230198
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.443 AC: 607377AN: 1370848Hom.: 137737 Cov.: 20 AF XY: 0.447 AC XY: 306248AN XY: 685226 show subpopulations
GnomAD4 exome
AF:
AC:
607377
AN:
1370848
Hom.:
Cov.:
20
AF XY:
AC XY:
306248
AN XY:
685226
Gnomad4 AFR exome
AF:
AC:
15069
AN:
31846
Gnomad4 AMR exome
AF:
AC:
20816
AN:
42796
Gnomad4 ASJ exome
AF:
AC:
10675
AN:
25280
Gnomad4 EAS exome
AF:
AC:
27234
AN:
39028
Gnomad4 SAS exome
AF:
AC:
48793
AN:
82516
Gnomad4 FIN exome
AF:
AC:
22676
AN:
52672
Gnomad4 NFE exome
AF:
AC:
433611
AN:
1033718
Gnomad4 Remaining exome
AF:
AC:
25691
AN:
57362
Heterozygous variant carriers
0
16371
32741
49112
65482
81853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
13166
26332
39498
52664
65830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.456 AC: 69355AN: 152016Hom.: 16044 Cov.: 33 AF XY: 0.461 AC XY: 34282AN XY: 74312 show subpopulations
GnomAD4 genome
AF:
AC:
69355
AN:
152016
Hom.:
Cov.:
33
AF XY:
AC XY:
34282
AN XY:
74312
Gnomad4 AFR
AF:
AC:
0.469192
AN:
0.469192
Gnomad4 AMR
AF:
AC:
0.491813
AN:
0.491813
Gnomad4 ASJ
AF:
AC:
0.408357
AN:
0.408357
Gnomad4 EAS
AF:
AC:
0.638331
AN:
0.638331
Gnomad4 SAS
AF:
AC:
0.58749
AN:
0.58749
Gnomad4 FIN
AF:
AC:
0.430966
AN:
0.430966
Gnomad4 NFE
AF:
AC:
0.422189
AN:
0.422189
Gnomad4 OTH
AF:
AC:
0.472909
AN:
0.472909
Heterozygous variant carriers
0
1967
3933
5900
7866
9833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at